Evidence for Generalizability of Edaravone Efficacy using a Novel Machine Learning Risk-based Subgroup Analysis Tool

Benjamin Rix Brooks, Erik P. Pioro, Danielle Beaulieu, Albert A. Taylor, Mark Schactman, Mike Keymer, Wendy Agnese, Johnna Perdrizet, Stephen Apple & David L. Ennist 

DOI: 10.1080/21678421.2021.1927102

Published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, on July 10, 2021.  This article is accessible on-line by clicking here.